Home > Signal Pathway > AMQUAR单克隆抗体抑制剂 > AMQUAR 单克隆抗体抑制剂

AMQUAR 单克隆抗体抑制剂


  • Etanercept MA1022

    Etanercept, a TNFα receptor Fc fusion protein that binds to IgG1, is used for the treatment of rheumatic disease and psoriasis.

    More
  • Evolocumab MA1023

    Evolocumab (Repatha, AMG 145) is a fully human monoclonal antibody against PCSK9, significantly reduces low-density lipoprotein-cholesterol (LDL-C) levels.

    More
  • Gemtuzumab MA1024

    Gemtuzumab, a humanized anti-CD33 monoclonal antibody, is used to treat patients with previously untreated or recurrent acute myelogenous leukemia (AML).

    More
  • Golimumab MA1025

    Golimumab is a fully human anti-TNF IgG1κ monoclonal antibody that acts principally by targeting and neutralizingTNF to prevent inflammation and destruction of cartilage and bone.

    More
  • Ibritumomab tiuxetan MA1026

    Ibritumomab tiuxetan, a radioactive yttrium-90-conjugated monoclonal antibody to CD20, has demonstrated therapeutic efficacy with durable responses and allows delivery of ionizing radiation directly to the tumor site, while minimizing toxicity to normal tissue.

    More
  • Current page4, Total Pages8, Total Record38 First Prev 23456 Next Last Goto